Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Flick, ED"'
Autor:
Wagner, I, Durie, BG, Jagannath, S, Narang, M, Terebelo, HR, Gasparetto, C, Toomey, K, Hardin, JW, Kitali, A, Yue, L, Agarwal, A, Srinivasan, S, Flick, ED, Rifkin, RM, Abonour, R
Publikováno v:
In Value in Health May 2018 21 Supplement 1:S6-S6
Autor:
Flick ED, Habel LA, Chan KA, Haque R, Quinn VP, Van Den Eeden SK, Sternfeld B, Orav EJ, Seeger JD, Quesenberry CP Jr., Caan BJ
Publikováno v:
Drugs; 2009, Vol. 69 Issue 11, p1445-1457, 13p
Autor:
Flick ED; Worldwide Health Economics and Outcomes Research (HEOR), Bristol Myers Squibb, San Francisco, CA, USA., Terebelo HR; Providence Cancer Institute, Southfield, MI, USA., Fish S; Worldwide Health Economics and Outcomes Research (HEOR), Bristol Myers Squibb, San Francisco, CA, USA., Kitali A; US Medical Affairs, Bristol Myers Squibb, Summit, NJ, USA., Mahajan V; Corporate Medical Affairs, Global Scientific Communications, Bristol Myers Squibb, Summit, NJ, USA., Nifenecker M; Research and Early Development Alliances, Bristol Myers Squibb, Summit, NJ, USA., Sullivan K; Worldwide Health Economics and Outcomes Research (HEOR), Bristol Myers Squibb, San Francisco, CA, USA., Thaler P; US Medical Affairs, Bristol Myers Squibb, Summit, NJ, USA., Ussery S; US Medical Affairs, Bristol Myers Squibb, Summit, NJ, USA., Grinblatt DL; NorthShore University HealthSystem, Evanston, IL, USA.
Publikováno v:
The oncologist [Oncologist] 2023 Aug 03; Vol. 28 (8), pp. 657-663.
Autor:
Tomlinson B; Seidman Cancer Center, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio. Electronic address: Benjamin.Tomlinson@UHhospitals.org., de Lima M; Department of Hematology, Ohio State University, Columbus, Ohio., Cogle CR; Division of Hematology and Oncology, Department of Medicine, University of Florida, Gainesville, Florida., Thompson MA; Aurora Research Institute, Advocate Aurora Health, Milwaukee, Wisconsin., Grinblatt DL; NorthShore Medical Group, NorthShore University Health System, Evanston, Illinois., Pollyea DA; University of Colorado Cancer Center, Aurora, Colorado., Komrokji RS; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, Florida., Roboz GJ; Weill Cornell College of Medicine and New York-Presbyterian Hospital, New York, New York., Savona MR; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Sekeres MA; Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Abedi M; University of California Davis, Comprehensive Cancer Center, Sacramento, California., Garcia-Manero G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas., Kurtin SE; University of Arizona Cancer Center, Tucson, Arizona., Maciejewski JP; Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Patel JL; Department of Pathology, University of Utah and ARUP Laboratories, Salt Lake City, Utah., Revicki DA; Outcomes Research Consulting, Sarasota, Florida., George TI; Department of Pathology, University of Utah and ARUP Laboratories, Salt Lake City, Utah., Flick ED; Bristol Myers Squibb, Princeton, New Jersey., Kiselev P; Bristol Myers Squibb, Princeton, New Jersey., Louis CU; Bristol Myers Squibb, Princeton, New Jersey., DeGutis IS; Bristol Myers Squibb, Princeton, New Jersey., Nifenecker M; Bristol Myers Squibb, Princeton, New Jersey., Erba HP; Duke Cancer Institute, North Carolina., Steensma DP; Dana-Farber Cancer Institute, Boston, Massachusetts., Scott BL; Fred Hutchinson Cancer Research Center, Seattle, Washington.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2023 Jul; Vol. 29 (7), pp. 460.e1-460.e9. Date of Electronic Publication: 2023 Apr 21.
Autor:
Mikita JS; Mikita Edge LLC, Salt Lake City, UT, USA., Mitchel J; Target Health LLC, New York, NY, USA., Gatto NM; Pfizer, New York, NY, USA., Laschinger J; U.S. Food and Drug Administration, Silver Spring, MD, USA., Tcheng JE; Duke Clinical Research Institute, Durham, NC, USA., Zeitler EP; Duke Clinical Research Institute, Durham, NC, USA., Swern AS; Celgene Corporation, Summit, NJ, USA., Flick ED; Celgene Corporation, Summit, NJ, USA., Dowd C; Cystic Fibrosis Foundation, Bethesda, MD, USA., Lystig T; Medtronic, Minneapolis, MN, USA., Calvert SB; Clinical Trials Transformation Initiative, 200 Morris St, Durham, NC, 27701, USA. sara.calvert@duke.edu.
Publikováno v:
Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2021 Jan; Vol. 55 (1), pp. 6-18. Date of Electronic Publication: 2020 Jun 22.
Autor:
Ailawadhi S; Mayo Clinic, Jacksonville, Florida., Jagannath S; Mount Sinai Hospital, New York, New York., Lee HC; The University of Texas MD Anderson Cancer Center, Houston, Texas., Narang M; US Oncology Research, Columbia, Maryland., Rifkin RM; Rocky Mountain Cancer Centers, US Oncology Research, Denver, Colorado., Terebelo HR; Providence Cancer Institute, Southfield, Michigan., Durie BGM; Cedars-Sinai Medical Center, Los Angeles, California., Toomey K; Steeplechase Cancer Center, Somerville, New Jersey., Hardin JW; University of South Carolina, Columbia, South Carolina., Gasparetto CJ; Duke University Medical Center, Durham, North Carolina., Wagner L; Wake Forest School of Medicine, Winston-Salem, North Carolina., Omel JL; Myeloma Research Advocate/Advisor, Grand Island, Nebraska., He M; Bristol-Myers Squibb, Summit, New Jersey., Yue L; Bristol-Myers Squibb, Summit, New Jersey., Flick ED; Bristol-Myers Squibb, Summit, New Jersey., Agarwal A; Bristol-Myers Squibb, Summit, New Jersey., Abonour R; Indiana University, Indianapolis, Indiana.
Publikováno v:
Cancer [Cancer] 2020 Oct 01; Vol. 126 (19), pp. 4332-4340. Date of Electronic Publication: 2020 Jul 24.
Autor:
Sharman JP; Willamette Valley Cancer Institute US Oncology Eugene Oregon USA., Cocks K; Adelphi Values Bollington Cheshire UK., Nabhan C; Caris Life Sciences Dallas Texas USA.; University of South Carolina Columbia South Carolina USA., Lamanna N; Division of Hematology and Oncology Department of Medicine New York-Presbyterian/Columbia University Medical Center New York New York USA., Kay NE; Division of Hematology Mayo Clinic Rochester Minnesota USA., Grinblatt DL; NorthShore University HealthSystem Evanston Illinois USA., Flowers CR; MD Anderson Cancer Center University of Texas Houston Texas USA., Davids MS; Department of Medical Oncology Dana-Farber Cancer Institute Boston Massachusetts USA., Kiselev P; Bristol Myers Squibb Princeton New Jersey USA., Swern AS; Bristol Myers Squibb Princeton New Jersey USA., Sullivan K; Bristol Myers Squibb Princeton New Jersey USA., Gharibo MM; Bristol Myers Squibb Princeton New Jersey USA., Flick ED; Bristol Myers Squibb Princeton New Jersey USA., Trigg A; Adelphi Values Bollington Cheshire UK., Mato A; Memorial Sloan Kettering Cancer Center New York New York USA.
Publikováno v:
EJHaem [EJHaem] 2020 Jul 26; Vol. 1 (1), pp. 188-198. Date of Electronic Publication: 2020 Jul 26 (Print Publication: 2020).
Autor:
Pollyea DA; Department of Medicine Division of Hematology University of Colorado Aurora Colorado USA., George TI; University of Utah and ARUP Laboratories Salt Lake City Utah USA., Abedi M; University of California Davis Sacramento California USA., Bejar R; Moores Cancer Center University of California San Diego Health La Jolla California USA., Cogle CR; University of Florida Gainesville Florida USA., Foucar K; University of New Mexico Health Sciences Center Albuquerque New Mexico USA., Garcia-Manero G; MD Anderson Cancer Center University of Texas Houston Texas USA., Grinblatt DL; NorthShore University Health System Evanston Illinois USA., Komrokji RS; H. Lee Moffitt Cancer Center Tampa Florida USA., Maciejewski JP; Cleveland Clinic Foundation Cleveland Ohio USA., Revicki DA; Evidera Bethesda Maryland USA., Roboz GJ; Weill Cornell College of Medicine New York New York USA., Savona MR; Vanderbilt-Ingram Cancer Center Vanderbilt University School of Medicine Nashville Tennessee USA., Scott BL; Fred Hutchinson Cancer Research Center Seattle Washington USA., Sekeres MA; Cleveland Clinic Foundation Cleveland Ohio USA., Thompson MA; Advocate Aurora Health Advocate Aurora Research Institute Milwaukee Wisconsin USA., Kurtin SE; University of Arizona Cancer Center Tucson Arizona USA., Louis CU; Bristol-Myers Squibb Summit New Jersey USA., Nifenecker M; Bristol-Myers Squibb Summit New Jersey USA., Flick ED; Bristol-Myers Squibb San Francisco California USA., Swern AS; Bristol-Myers Squibb Summit New Jersey USA., Kiselev P; Bristol-Myers Squibb Summit New Jersey USA., Steensma DP; Dana-Farber Cancer Institute Boston Massachusetts USA., Erba HP; Duke University Durham North Carolina USA.
Publikováno v:
EJHaem [EJHaem] 2020 Jun 30; Vol. 1 (1), pp. 58-68. Date of Electronic Publication: 2020 Jun 30 (Print Publication: 2020).
Autor:
Jagannath S; Department of Hematology and Medical Oncology, Mount Sinai Hospital, New York, NY. Electronic address: sundar.jagannath@mountsinai.org., Rifkin RM; Department of Medical Oncology/Hematology, Rocky Mountain Cancer Centers US Oncology, Denver, CO., Gasparetto CJ; Department of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC., Toomey K; Department of Internal Medicine, Medical Oncology, and Hematology, Steeplechase Cancer Center, Somerville, NJ., Durie BGM; Department of Hematology/Oncology, Cedars-Sinai Medical Center, Los Angeles, CA., Hardin JW; Department of Epidemiology and Biostatistics, University of South Carolina, Columbia, SC., Terebelo HR; Department of Hematology, Internal Medicine, and Medical Oncology, Providence Cancer Institute, Southfield, MI., Wagner L; Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, NC., Narang M; Department of Medical Oncology/Hematology, US Oncology Research, Columbia, MD., Ailawadhi S; Department of Hematology, Mayo Clinic, Jacksonville, FL., Omel JL; Myeloma Research Advocate/Advisor, Grand Island, NE., Srinivasan S; Celgene Corporation, Summit, NJ., He M; Celgene Corporation, Summit, NJ., Ung B; Celgene Corporation, Summit, NJ., Kitali A; Celgene Corporation, Summit, NJ., Flick ED; Celgene Corporation, Summit, NJ., Agarwal A; Celgene Corporation, Summit, NJ., Abonour R; Department of Hematology/Oncology, Indiana University, Indianapolis, IN.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2020 May; Vol. 20 (5), pp. 272-276. Date of Electronic Publication: 2019 Oct 14.
Autor:
Mato A; Memorial Sloan Kettering Cancer Center, New York, NY., Nabhan C; Aptitude Health, Atlanta, GA., Lamanna N; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian/Columbia University Medical Center, New York, NY., Kay NE; Division of Hematology, Mayo Clinic, Rochester, MN., Grinblatt DL; NorthShore University HealthSystem, Evanston, IL., Flowers CR; Department of Hematology and Medical Oncology/Winship Cancer Institute, Emory University, Atlanta, GA., Farber CM; Atlantic Hematology Oncology, Carol G. Simon Cancer Center, Morristown, NJ., Davids MS; Dana-Farber Cancer Institute, Boston, MA., Swern AS; Bristol-Myers Squibb, Summit, NJ., Sullivan K; Bristol-Myers Squibb, Overland Park, KS., Flick ED; Bristol-Myers Squibb, San Francisco, CA., Gressett Ussery SM; Karyopharm Therapeutics, Dallas, TX; and., Gharibo M; Bristol-Myers Squibb, Summit, NJ., Kiselev P; Bristol-Myers Squibb, Summit, NJ., Sharman JP; Willamette Valley Cancer Institute, US Oncology, Eugene, OR.
Publikováno v:
Blood advances [Blood Adv] 2020 Apr 14; Vol. 4 (7), pp. 1407-1418.